Globus Medical Quarterly Cash Flow Statement
NYSE: GMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Globus Medical free cash flow
In the quarter ended Jun 30, 2026, Globus Medical generated $209.7 million of operating cash flow and spent $33.2 million on capital expenditures. That left free cash flow of $176.6 million, a free-cash-flow margin of 22.4% of revenue. Free cash flow was up 464.1% from the prior year's $31.3 million.
Globus Medical returned $136.1 million to shareholders through share repurchases, equal to 77% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Globus Medical cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 151.57M | 124.30M | 140.59M | 118.97M | 202.85M | 75.46M | 26.50M | 51.84M | 31.76M | -7.12M | 15.03M | 998.00K |
| Net Income growth (YoY) | -25.28% | +64.72% | +430.44% | +129.50% | +538.68% | — | +76.30% | +5093.99% | -44.97% | -114.49% | -69.97% | -97.90% |
| Depreciation & Amortization | 69.50M | 69.86M | 69.01M | 71.55M | 70.63M | 65.65M | 67.59M | 66.95M | 63.59M | 55.26M | 71.95M | 37.39M |
| Stock-Based Compensation | 13.38M | 12.62M | 11.42M | 11.54M | 13.62M | 13.21M | 11.91M | 12.21M | 12.81M | 17.26M | 12.45M | 22.75M |
| Change in Working Capital | -48.81M | -18.03M | -37.37M | -18.23M | -13.21M | 18.65M | 31.13M | 17.17M | -88.15M | -49.35M | -28.15M | -33.40M |
| Operating Cash Flow | 209.74M | 202.36M | 248.59M | 249.69M | 77.86M | 177.30M | 210.34M | 203.65M | 54.26M | 52.39M | 104.67M | 50.48M |
| Capital Expenditures | -33.17M | -39.62M | -46.20M | -35.82M | -46.56M | -36.10M | -17.11M | -41.95M | -27.80M | -28.57M | -22.88M | -21.53M |
| Investing Cash Flow | -129.05M | -182.67M | -111.45M | -75.84M | -299.11M | 131.38M | -104.12M | -14.97M | -10.38M | -46.58M | 320.62M | -80.86M |
| Share Repurchases | -136.06M | 0 | -45.00M | -40.00M | -25.00M | -190.45M | -1.00M | 0 | -1.47M | -83.32M | — | — |
| Debt Repaid | 0 | 0 | — | — | 0 | -449.99M | — | — | — | — | — | — |
| Financing Cash Flow | -134.50M | 18.20M | 13.21M | -32.04M | -24.94M | -635.40M | 59.73M | 19.58M | 8.71M | -115.72M | -237.27M | 1.43M |
| Net Change in Cash | -53.20M | 34.79M | 154.39M | 142.32M | -231.82M | -323.17M | 161.67M | 212.34M | 56.36M | -113.23M | 187.67M | -26.83M |
| Free Cash Flow | 176.57M | 162.75M | 202.39M | 213.88M | 31.30M | 141.20M | 193.23M | 161.70M | 26.46M | 23.82M | 81.79M | 28.95M |
This table shows 12 quarterly periods of Globus Medical's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GMED's reporting calendar. What is a cash flow statement?